Pages that link to "Q48331913"
Jump to navigation
Jump to search
The following pages link to Increased temporal cortex CREB concentrations and antidepressant treatment in major depression (Q48331913):
Displaying 50 items.
- The role of the hippocampus in the pathophysiology of major depression (Q24561923) (← links)
- Neuropeptides in depression: role of VGF (Q24647788) (← links)
- Phosphodiesterases in neurodegenerative disorders (Q27026359) (← links)
- The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment (Q28303736) (← links)
- Neurobiology of depression (Q29619932) (← links)
- The GABAergic deficit hypothesis of major depressive disorder. (Q30464954) (← links)
- Stress-induced structural remodeling in hippocampus: prevention by lithium treatment (Q30542879) (← links)
- Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice (Q30557339) (← links)
- Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. (Q30726106) (← links)
- Identification of genes regulated by chronic social stress in the rat dorsal raphe nucleus (Q33246245) (← links)
- cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor (Q33554709) (← links)
- Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair (Q33624262) (← links)
- Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression (Q33697992) (← links)
- Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection (Q33744362) (← links)
- Neural plasticity to stress and antidepressant treatment (Q33772697) (← links)
- Molecular and cellular mechanisms of cognitive function: implications for psychiatric disorders (Q33842573) (← links)
- Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia (Q33872654) (← links)
- Future antidepressants: what is in the pipeline and what is missing? (Q33980902) (← links)
- Pharmacogenomics of suicidal events (Q34066818) (← links)
- Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders (Q34108573) (← links)
- Molecular analysis, mutation screening, and association study of adenylate cyclase type 9 gene (ADCY9) in mood disorders (Q34113748) (← links)
- Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. (Q34165326) (← links)
- Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment (Q34186921) (← links)
- Role of neurotrophic factors in the etiology and treatment of mood disorders (Q34303344) (← links)
- Course of illness, hippocampal function, and hippocampal volume in major depression (Q34331120) (← links)
- Elucidating biological risk factors in suicide: Role of protein kinase A (Q34520517) (← links)
- Pathophysiology of depression: the concept of synaptic plasticity (Q34548351) (← links)
- The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression (Q34582990) (← links)
- Synaptic plasticity and mood disorders (Q34622373) (← links)
- Voxelwise quantification of [(11)C](R)-rolipram PET data: a comparison between model-based and data-driven methods (Q34628071) (← links)
- Stress, depression, and neuroplasticity: a convergence of mechanisms (Q34686632) (← links)
- NEUROBIOLOGY OF ADULT AND TEENAGE SUICIDE (Q34695129) (← links)
- What can post-mortem studies tell us about the pathoetiology of suicide? (Q34701742) (← links)
- Signaling networks in the pathophysiology and treatment of mood disorders (Q34778245) (← links)
- The neurobiology of treatment response to antidepressants and mood stabilizing medications. (Q34783154) (← links)
- Antidepressants and neuroplasticity (Q34785757) (← links)
- CREB1 gene polymorphisms combined with environmental risk factors increase susceptibility to major depressive disorder (MDD). (Q35144888) (← links)
- Affective disorders, antidepressant drugs and brain metabolism (Q35204087) (← links)
- Neurobiological principles of bipolar affective disorders (Q35206461) (← links)
- Neural plasticity: consequences of stress and actions of antidepressant treatment (Q35236802) (← links)
- Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: Evidence, limitations, and implications (Q35580581) (← links)
- Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression (Q35587678) (← links)
- Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression (Q35592881) (← links)
- CREB1 Genotype Modulates Adaptive Reward-Based Decisions in Humans (Q35653432) (← links)
- Hippocampal neurogenesis, depressive disorders, and antidepressant therapy (Q35869161) (← links)
- Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseases (Q35869731) (← links)
- Chronic stress, depression and antidepressants: effects on gene transcription in the hippocampus (Q36089265) (← links)
- Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus (Q36110594) (← links)
- Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder (Q36223414) (← links)
- Implications of the cAMP signaling pathway in psychiatric disorders: a systematic review of the evidence. (Q36237091) (← links)